Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
Fund managers haven’t disclosed any holdings of EXAS yet.
EXAS Hedge Fund Activity: Q1 2026 in Review
7 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2026, worth a combined $4.92M — down 100% from $17.9B a quarter earlier.
Sellers outnumbered buyers: 692 funds closed out of EXAS and 0 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Pinkerton Retirement Specialists, adding an estimated $22.1K. The largest seller was BlackRock, exiting entirely with an estimated $1.54B sold.
- 7 institutional investors held Exact Sciences (EXAS) as of Q1 2026, down from 711 in Q4 2025.
- Funds reported $4.92M of Exact Sciences stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Exact Sciences positions in Q1 2026 and 692 closed out, a net change of -692 holders.
- The largest Exact Sciences buyer in Q1 2026 was Pinkerton Retirement Specialists, an estimated $22.1K added.
- The largest Exact Sciences seller in Q1 2026 was BlackRock, an estimated $1.54B sold.
Based on aggregated 13F filings for Q1 2026.